** Shares of Australia's Universal Biosensors UBI.AX rise
as much as 13.1% to A$0.345, hitting their highest since August
2022
** Medical diagnostics firm says its first Xprecia Prime
devices were delivered in Europe following about 10 months of
delays due to supply chain snags
** Says expects much better sales performance from its
coagulation business during 2023
** Set to gain most since November 2022, if gains hold
** Stock fell 77.3% in 2022
(Reporting by Rishav Chatterjee in Bengaluru)
((Rishav.Chatterjee@thomsonreuters.com;))